F Breitenecker

514 total citations
16 papers, 427 citations indexed

About

F Breitenecker is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, F Breitenecker has authored 16 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Hepatology. Recurrent topics in F Breitenecker's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). F Breitenecker is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). F Breitenecker collaborates with scholars based in Austria, United States and Italy. F Breitenecker's co-authors include Armin Rieger, Maximilian C. Aichelburg, Thomas Reiberger, Katharina Grabmeier‐Pfistershammer, Markus Peck‐Radosavljevic, Norbert Kohrgruber, Mattias Mandorfer, Athanasios Makristathis, Georg Stingl and A Aichelburg and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

F Breitenecker

16 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Breitenecker Austria 12 292 234 138 129 42 16 427
Maximilian C. Aichelburg Austria 14 382 1.3× 250 1.1× 147 1.1× 195 1.5× 43 1.0× 32 533
G. Antonucci Italy 12 495 1.7× 294 1.3× 107 0.8× 337 2.6× 106 2.5× 36 655
Jason Eccleston United States 6 200 0.7× 54 0.2× 82 0.6× 152 1.2× 35 0.8× 13 359
H. Zylberberg France 10 391 1.3× 141 0.6× 40 0.3× 436 3.4× 35 0.8× 32 571
Vincenzo Sangiovanni Italy 10 91 0.3× 123 0.5× 58 0.4× 63 0.5× 19 0.5× 23 303
Patricia Méndez United States 12 317 1.1× 129 0.6× 40 0.3× 328 2.5× 44 1.0× 25 430
Julia O’Brien United Kingdom 9 400 1.4× 74 0.3× 49 0.4× 399 3.1× 31 0.7× 12 510
Caroline Roussillon France 7 177 0.6× 149 0.6× 45 0.3× 82 0.6× 65 1.5× 12 381
Hulya Levendoglu United States 9 150 0.5× 88 0.4× 134 1.0× 27 0.2× 26 0.6× 17 315
Kalayanee Atamasirikul Thailand 11 194 0.7× 147 0.6× 29 0.2× 72 0.6× 41 1.0× 25 343

Countries citing papers authored by F Breitenecker

Since Specialization
Citations

This map shows the geographic impact of F Breitenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Breitenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Breitenecker more than expected).

Fields of papers citing papers by F Breitenecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Breitenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Breitenecker. The network helps show where F Breitenecker may publish in the future.

Co-authorship network of co-authors of F Breitenecker

This figure shows the co-authorship network connecting the top 25 collaborators of F Breitenecker. A scholar is included among the top collaborators of F Breitenecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Breitenecker. F Breitenecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mandorfer, Mattias, F Breitenecker, Thomas Reiberger, et al.. (2016). Impact of Early Initiation of Antiretroviral Therapy in Patients with Acute HIV Infection in Vienna, Austria. PLoS ONE. 11(4). e0152910–e0152910. 31 indexed citations
2.
Aichelburg, Maximilian C., Mattias Mandorfer, F Breitenecker, et al.. (2014). The association of smoking with IGRA and TST results in HIV-1-infected subjects. The International Journal of Tuberculosis and Lung Disease. 18(6). 709–716. 7 indexed citations
3.
Mandorfer, Mattias, B.A. Payer, Bernhard Scheiner, et al.. (2013). Health‐related quality of life and severity of fatigue in HIV/HCV co‐infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin. Liver International. 34(1). 69–77. 26 indexed citations
4.
Mandorfer, Mattias, Thomas Reiberger, B.A. Payer, et al.. (2013). Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV‐/HCV‐coinfected patients: the role of metabolic factors and elevated GGT levels. Journal of Viral Hepatitis. 21(1). 33–41. 12 indexed citations
5.
Aichelburg, Maximilian C., Thomas Reiberger, F Breitenecker, et al.. (2013). Reversion and Conversion of Interferon-γ Release Assay Results in HIV-1–Infected Individuals. The Journal of Infectious Diseases. 209(5). 729–733. 21 indexed citations
6.
Payer, B.A., Thomas Reiberger, F Breitenecker, et al.. (2012). The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. Journal of Infection. 65(2). 142–149. 10 indexed citations
7.
Reiberger, Thomas, B.A. Payer, Arnulf Ferlitsch, et al.. (2012). A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin. Antiviral Therapy. 17(7). 1327–1334. 23 indexed citations
8.
Mandorfer, Mattias, Thomas Reiberger, B.A. Payer, et al.. (2012). Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients. AIDS. 27(2). 227–232. 38 indexed citations
9.
Aichelburg, Maximilian C., et al.. (2012). Prognostic Value of Indeterminate IFN-γ Release Assay Results in HIV-1 Infection. Journal of Clinical Microbiology. 50(8). 2767–2769. 15 indexed citations
10.
Mandorfer, Mattias, Thomas Reiberger, Arnulf Ferlitsch, et al.. (2012). Low Vitamin D serum levels are associated with liver fibrosis and impaired virologic response to chronic hepatitis C therapy with Pegifn+RBV in HIV/HCV coinfected patients. Zeitschrift für Gastroenterologie. 50(5). 1 indexed citations
11.
Payer, B.A., Thomas Reiberger, Judith Stift, et al.. (2012). 915 INFLUENCE OF PNPLA3 SNP ON HEPATIC STEATOSIS AND FIBROSIS PROGRESSION IN HIV-HCV COINFECTED PATIENTS. Journal of Hepatology. 56. S356–S356. 1 indexed citations
12.
Reiberger, Thomas, Lana Kosi, Judith Maresch, et al.. (2010). Mitochondrial Toxicity Is Associated with Virological Response in Patients with HIV and Hepatitis C Virus Coinfection Treated with Ribavirin and Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 202(1). 156–160. 11 indexed citations
13.
Aichelburg, Maximilian C., Armin Rieger, F Breitenecker, et al.. (2009). Detection and Prediction of Active Tuberculosis Disease by a Whole‐Blood Interferon‐γ Release Assay in HIV‐1–Infected Individuals. Clinical Infectious Diseases. 48(7). 954–962. 131 indexed citations
14.
Reiberger, Thomas, Arnulf Ferlitsch, Wolfgang Sieghart, et al.. (2009). HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension. Journal of Viral Hepatitis. 17(6). 400–409. 55 indexed citations
15.
Kohlberger, Petra, F Breitenecker, Alexandra Kaider, et al.. (1999). Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison.. PubMed. 19(3B). 2189–93. 34 indexed citations
16.
Kohlberger, Petra, Dirk Kieback, F Breitenecker, et al.. (1997). Epithelial and Stromal Estrogen and Progesterone Receptor Expression in Endometrial Cancer: True Color Computer-Assisted Image Analysis versus Subjective Scoring. Gynecologic Oncology. 64(3). 404–410. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026